Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Tiotropium Respimat inhaler and the risk of death in COPD.

Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, Dusser D, Joseph E, Kattenbeck S, Koenen-Bergmann M, Pledger G, Calverley P; TIOSPIR Investigators.

N Engl J Med. 2013 Oct 17;369(16):1491-501. doi: 10.1056/NEJMoa1303342. Epub 2013 Aug 30.

2.

Efficacy of disease-modifying therapies in relapsing remitting multiple sclerosis: a systematic comparison.

Freedman MS, Hughes B, Mikol DD, Bennett R, Cuffel B, Divan V, LaVallee N, Al-Sabbagh A.

Eur Neurol. 2008;60(1):1-11. doi: 10.1159/000127972. Epub 2008 Apr 25. Review.

3.

Efficacy of zileuton controlled-release tablets administered twice daily in the treatment of moderate persistent asthma: a 3-month randomized controlled study.

Nelson H, Kemp J, Berger W, Corren J, Casale T, Dube L, Walton-Bowen K, LaVallee N, Stepanians M.

Ann Allergy Asthma Immunol. 2007 Aug;99(2):178-84.

PMID:
17718106
4.

Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit.

Krug N, Hohlfeld JM, Geldmacher H, Larbig M, Heermann R, Lavallee N, Nguyen DT, Petzold U, Hermann R.

Allergy. 2005 Mar;60(3):354-9.

PMID:
15679722
5.

Intranasal loteprednol etabonate in healthy male subjects: pharmacokinetics and effects on endogenous cortisol.

Hermann R, Locher M, Siebert-Weigel M, LaVallee N, Derendorf H, Hochhaus G.

J Clin Pharmacol. 2004 May;44(5):510-9.

PMID:
15102872
6.

A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease.

Castaldo RS, Celli BR, Gomez F, LaVallee N, Souhrada J, Hanrahan JP.

Clin Ther. 2003 Feb;25(2):542-57.

PMID:
12749513
7.
8.

Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma.

Martin RJ, Kraft M, Beaucher WN, Kiechel F, Sublett JL, LaVallee N, Shilstone J.

Ann Allergy Asthma Immunol. 1999 Aug;83(2):121-6.

PMID:
10480584
9.

Tri-Nasal triamcinolone acetonide nasal spray 200 and 400 micrograms qd versus placebo and Nasacort triamcinolone acetonide nasal aerosol 440 micrograms qd in patients suffering from seasonal allergic rhinitis during the grass season.

Rosenthal R, Berger W, Bronsky E, Dockhorn R, Korenblat P, Lampl K, Lumry W, Pollard S, Raphael G, Rohr C, Shapiro G, Valentine M, Wanderer A, Fleming L, LaVallee N, Stepanians M, Karafilidis J, Shilstone J, Ellis E.

Am J Rhinol. 1998 Nov-Dec;12(6):427-33.

PMID:
9883300
10.

A pharmacokinetic comparison of two oral liquid glucocorticoid formulations.

Kamada AK, Wiener MB, LaVallee NM, Scott MB, Selner JC, Szefler SJ.

Pharmacotherapy. 1997 Mar-Apr;17(2):353-6.

PMID:
9085328
11.

Exercise and energy intake: effect of substrate oxidation.

Alméras N, Lavallée N, Després JP, Bouchard C, Tremblay A.

Physiol Behav. 1995 May;57(5):995-1000.

PMID:
7610155
12.

Caries incidence in patients with dementia.

Jones JA, Lavallee N, Alman J, Sinclair C, Garcia RI.

Gerodontology. 1993 Dec;10(2):76-82.

PMID:
7713530
13.

Fairness in prospective payment: a clustering approach.

Stefos T, LaVallee N, Holden F.

Health Serv Res. 1992 Jun;27(2):239-61.

14.

Human resting energy expenditure in relation to dietary potassium.

Dériaz O, Thériault G, Lavallée N, Fournier G, Nadeau A, Bouchard C.

Am J Clin Nutr. 1991 Oct;54(4):628-34.

PMID:
1897469
15.

Nutritional determinants of the increase in energy intake associated with a high-fat diet.

Tremblay A, Lavallée N, Alméras N, Allard L, Després JP, Bouchard C.

Am J Clin Nutr. 1991 May;53(5):1134-7.

PMID:
2021125

Supplemental Content

Loading ...
Support Center